Foresite Capital Management IV, 10% Owner of Eikon Therapeutics EIKN, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $1000K. The latest trade was on 02/04.

FI

FI

Foresite Capital Management IV

10% Owner

Company

Eikon Therapeutics EIKN

First filing

23/02/22

Trades

35 trades

Buys / sales

3 / 0

12-month net buying

$1M

Last trade

02/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Eikon TherapeuticsEIKN	Open-market buy	02/04	02/06	55,555 sh	$18.00	$999,990	+4.4%
KB Kinnate Biopharma	Open-market buy	23/05/08	23/05/10	1,780,000 sh2 trades	$2.80avg.	$4,984,000	No record